Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
- Resource Type
- journal article
- Source
- Journal of Clinical Endocrinology & Metabolism; Aug 01, 2019, Vol. 104 Issue 8, p3437-3449, 13p
- Subject
- Language
- ISSN
- 0021972X